Logo image of BLMZ

BLOOMZ INC (BLMZ) Stock Fundamental Analysis

NASDAQ:BLMZ - Nasdaq - KYG1180K1168 - Common Stock - Currency: USD

0.2305  -0.02 (-9.36%)

After market: 0.2929 +0.06 (+27.07%)

Fundamental Rating

3

Taking everything into account, BLMZ scores 3 out of 10 in our fundamental rating. BLMZ was compared to 72 industry peers in the Entertainment industry. The financial health of BLMZ is average, but there are quite some concerns on its profitability. BLMZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year BLMZ has reported negative net income.
In the past year BLMZ has reported a negative cash flow from operations.
BLMZ Yearly Net Income VS EBIT VS OCF VS FCFBLMZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -100M -200M -300M -400M -500M

1.2 Ratios

Looking at the Return On Assets, with a value of -32.84%, BLMZ is doing worse than 84.72% of the companies in the same industry.
BLMZ's Return On Equity of -49.55% is on the low side compared to the rest of the industry. BLMZ is outperformed by 65.28% of its industry peers.
Industry RankSector Rank
ROA -32.84%
ROE -49.55%
ROIC N/A
ROA(3y)-11.7%
ROA(5y)N/A
ROE(3y)-16.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLMZ Yearly ROA, ROE, ROICBLMZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

BLMZ has a worse Gross Margin (31.15%) than 63.89% of its industry peers.
In the last couple of years the Gross Margin of BLMZ has grown nicely.
BLMZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.9%
GM growth 5YN/A
BLMZ Yearly Profit, Operating, Gross MarginsBLMZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

6

2. Health

2.1 Basic Checks

BLMZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BLMZ has been increased compared to 1 year ago.
The debt/assets ratio for BLMZ has been reduced compared to a year ago.
BLMZ Yearly Shares OutstandingBLMZ Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M 10M
BLMZ Yearly Total Debt VS Total AssetsBLMZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

BLMZ has an Altman-Z score of 10.18. This indicates that BLMZ is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 10.18, BLMZ belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
BLMZ has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.05, BLMZ is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 10.18
ROIC/WACCN/A
WACC5.27%
BLMZ Yearly LT Debt VS Equity VS FCFBLMZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M -200M 400M -400M

2.3 Liquidity

A Current Ratio of 2.81 indicates that BLMZ has no problem at all paying its short term obligations.
BLMZ's Current ratio of 2.81 is amongst the best of the industry. BLMZ outperforms 83.33% of its industry peers.
A Quick Ratio of 2.81 indicates that BLMZ has no problem at all paying its short term obligations.
BLMZ has a better Quick ratio (2.81) than 84.72% of its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 2.81
BLMZ Yearly Current Assets VS Current LiabilitesBLMZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

BLMZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -939.28%.
BLMZ shows a strong growth in Revenue. In the last year, the Revenue has grown by 79.79%.
BLMZ shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 38.71% yearly.
EPS 1Y (TTM)-939.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1411%
Revenue 1Y (TTM)79.79%
Revenue growth 3Y38.71%
Revenue growth 5YN/A
Sales Q2Q%71.48%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BLMZ Yearly Revenue VS EstimatesBLMZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 50M 100M 150M 200M

0

4. Valuation

4.1 Price/Earnings Ratio

BLMZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BLMZ Price Earnings VS Forward Price EarningsBLMZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLMZ Per share dataBLMZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.05 -0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

BLMZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLOOMZ INC

NASDAQ:BLMZ (7/23/2025, 4:36:10 PM)

After market: 0.2929 +0.06 (+27.07%)

0.2305

-0.02 (-9.36%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.65%
Inst Owner ChangeN/A
Ins Owners0.85%
Ins Owner ChangeN/A
Market Cap26.34M
AnalystsN/A
Price TargetN/A
Short Float %0.33%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.32
P/FCF N/A
P/OCF N/A
P/B 8.02
P/tB 10.26
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0.02
BVpS0.03
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -32.84%
ROE -49.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.15%
FCFM N/A
ROA(3y)-11.7%
ROA(5y)N/A
ROE(3y)-16.82%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.9%
GM growth 5YN/A
F-Score1
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 701.4%
Cap/Sales 27.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.81
Quick Ratio 2.81
Altman-Z 10.18
F-Score1
WACC5.27%
ROIC/WACCN/A
Cap/Depr(3y)383.76%
Cap/Depr(5y)N/A
Cap/Sales(3y)21.14%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-939.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1411%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)79.79%
Revenue growth 3Y38.71%
Revenue growth 5YN/A
Sales Q2Q%71.48%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-772.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-765.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-954.49%
OCF growth 3YN/A
OCF growth 5YN/A